Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$17.11 - $20.92 $1.73 Million - $2.12 Million
-101,200 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$17.21 - $20.65 $247,824 - $297,360
-14,400 Reduced 12.46%
101,200 $1.85 Million
Q4 2020

Feb 16, 2021

SELL
$17.76 - $21.24 $21,312 - $25,487
-1,200 Reduced 1.03%
115,600 $2.32 Million
Q3 2020

Nov 04, 2020

BUY
$17.99 - $22.22 $1.56 Million - $1.93 Million
86,900 Added 290.64%
116,800 $2.19 Million
Q2 2020

Jul 31, 2020

BUY
$14.25 - $22.46 $426,075 - $671,554
29,900 New
29,900 $672,000
Q1 2020

May 08, 2020

SELL
$12.66 - $20.08 $2.27 Million - $3.6 Million
-179,478 Closed
0 $0
Q4 2019

Feb 11, 2020

BUY
$17.07 - $20.64 $240,687 - $291,024
14,100 Added 8.53%
179,478 $3.46 Million
Q3 2019

Nov 01, 2019

SELL
$19.12 - $22.62 $305,920 - $361,920
-16,000 Reduced 8.82%
165,378 $3.28 Million
Q2 2019

Aug 13, 2019

BUY
$18.92 - $22.96 $2.2 Million - $2.68 Million
116,536 Added 179.72%
181,378 $3.83 Million
Q1 2019

May 13, 2019

SELL
$19.46 - $25.28 $354,172 - $460,096
-18,200 Reduced 21.92%
64,842 $1.32 Million
Q4 2018

Feb 14, 2019

SELL
$17.72 - $22.51 $2.16 Million - $2.75 Million
-122,058 Reduced 59.51%
83,042 $1.65 Million
Q3 2018

Nov 14, 2018

SELL
$15.39 - $19.38 $452,466 - $569,772
-29,400 Reduced 12.54%
205,100 $3.95 Million
Q2 2018

Aug 06, 2018

BUY
$14.63 - $19.6 $80,465 - $107,800
5,500 Added 2.4%
234,500 $3.58 Million
Q1 2018

May 03, 2018

BUY
$17.23 - $20.35 $3.95 Million - $4.66 Million
229,000 New
229,000 $4.29 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.93B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Mackay Shields LLC Portfolio

Follow Mackay Shields LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackay Shields LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mackay Shields LLC with notifications on news.